Zobrazeno 1 - 10 of 45 pro vyhledávání: '"Rosalie C. Mallant"'
1
Akademický článek
Dynamic clonal equilibrium and predetermined cancer risk in Barrett’s oesophagus
Autor: Pierre Martinez, Margriet R. Timmer, Chiu T. Lau, Silvia Calpe, Maria del Carmen Sancho-Serra, Danielle Straub, Ann-Marie Baker, Sybren L. Meijer, Fiebo J. W. ten Kate, Rosalie C. Mallant-Hent, Anton H. J. Naber, Arnoud H. A. M. van Oijen, Lubbertus C. Baak, Pieter Scholten, Clarisse J. M. Böhmer, Paul Fockens, Jacques J. G. H. M. Bergman, Carlo C. Maley, Trevor A. Graham, Kausilia K Krishnadath
Publikováno v: Nature Communications, Vol 7, Iss 1, Pp 1-10 (2016)
Barrett’s oesophagus is thought to be a precursor lesion for oesophageal cancer, and predicting the benign lesions that progress to cancer is clinically important. Here, the authors use FISH to study the clonal evolution of Barrett’s oesophagus a
Externí odkaz: https://doaj.org/article/30abe593d39a4da4b5f584456b184821
Zobrazit plný text záznamu
2
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI) a pragmatic, open-label, non-inferiority, randomised controlled trial
Autor: Reinier C A van Linschoten, Fenna M Jansen, Renske W M Pauwels, Lisa J T Smits, Femke Atsma, Wietske Kievit, Dirk J de Jong, Annemarie C de Vries, Paul J Boekema, Rachel L West, Alexander G L Bodelier, Ingrid A M Gisbertz, Frank H J Wolfhagen, Tessa E H Römkens, Maurice W M D Lutgens, Adriaan A van Bodegraven, Bas Oldenburg, Marieke J Pierik, Maurice G V M Russel, Nanne K de Boer, Rosalie C Mallant-Hent, Pieter C J ter Borg, Andrea E van der Meulen-de Jong, Jeroen M Jansen, Sita V Jansen, Adrianus C I T L Tan, C Janneke van der Woude, Frank Hoentjen, Desirée van Noord, Jildou Hoekstra, Johannes T. Kamphuis, Moniek H.P. Gorter, Aura A.J. van Esch
Publikováno v: Lancet Gastroenterology & Hepatology, 8, 4, pp. 343-355
Lancet Gastroenterology & Hepatology, 8, 343-355
The Lancet Gastroenterology and Hepatology, 8(4), 343-355. Elsevier Ltd
LADI study group and the Dutch Initiative on Crohn and Colitis 2023, ' Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI) : a pragmatic, open-label, non-inferiority, randomised controlled trial ', The Lancet Gastroenterology and Hepatology, vol. 8, no. 4, pp. 343-355 . https://doi.org/10.1016/S2468-1253(22)00434-4
The Lancet Gastroenterology and Hepatology, 8(4), 343-355. Elsevier Ltd.
Item does not contain fulltext BACKGROUND: Despite its effectiveness in treating Crohn's disease, adalimumab is associated with an increased risk of infections and high health-care costs. We aimed to assess clinical outcomes of increased adalimumab d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d4a13f67ca392c8811058105e50cf3a
https://repository.ubn.ru.nl/handle/2066/293716
Zobrazit plný text záznamu
3
Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progression
Autor: Bert C. Baak, Sybren L. Meijer, Angela Bureo Gonzalez, Roos E. Pouw, Jacques J. Bergman, Nahid Mostafavi, Lucas C. Duits, Pieter Scholten, Esther Klaver, Arnoud H. Van Oijen, Clarisse Bohmer, Ton Naber, Rosalie C. Mallant-Hent
Publikováno v: United European Gastroenterology Journal, 9(8), 929-937. SAGE Publications Inc.
United European gastroenterology journal, 9(8), 929-937. SAGE Publications Inc.
on behalf of the ReBus Study Group 2021, ' Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progression ', United European Gastroenterology Journal, vol. 9, no. 8, pp. 929-937 . https://doi.org/10.1002/ueg2.12114
United European Gastroenterology Journal
Background and Aims Barrett's esophagus (BE) is accompanied by an increased risk of developing esophageal cancer. Accurate risk‐stratification is warranted to improve endoscopic surveillance. Most data available on risk factors is derived from tert
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2494f89d279234627d26edcfd9a1eac6
http://www.scopus.com/inward/record.url?scp=85109169370&partnerID=8YFLogxK
Zobrazit plný text záznamu
4
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial
Autor: Jan van den Brande, Tessa Uiterwaal, Christianne J. Buskens, Juda Vecht, Robert E G J M Pierik, Job H.C. Peters, Nofel Mahmmod, John Maring, E. Joline de Groof, Toer W. Stevens, H. B. A. C. Stockmann, Pieter C. F. Stokkers, Karlien F. Bruin, Eric J. Hazebroek, Ailsa Hart, Arnold van de Laar, Hubert A Prins, Richard van Hillegersberg, Rachel L. West, Paul Kingma, Menno A. Brink, Pritesh Morar, Ruud Schouten, Marno C.M. Rijk, A Jeroen de Groof, Sijbrand Hofker, Annekatrien Depla, Bregje Mol, Janneke van der Woude, T. J. Gardenbroek, Janindra Warusavitarne, Bas Oldenburg, Edwin S. van der Zaag, Anna A. W. van Geloven, Rogier M P H Crolla, Emma J. Eshuis, Hans Brouwer, Meindert N. Sosef, Maria L Haasnoot, Geert R. D'Haens, Nynke Talstra, Marcel Spanier, Liekele Oostenbrug, Jeroen M. Jansen, Maarten J Boom, Donald L. van der Peet, Nanne K. H. de Boer, Willem A. Bemelman, Cyriel Y. Ponsioen, Rosalie C Mallant, Theo J.M. van Ditzhuijsen, Gerard Dijkstra, Alexander P.J. Houdijk, Willem A. Marsman, Djuna Cahen, Casper G. Noomen, Huib A. Cense, Esther C. J. Consten, Michael F. Gerhards, Ad A. van Bodegraven, Rob J. Lieverse, Andreas Marinelli, Sjoerd van der Werff, Clemens Bolwerk, Ernst Jan Spillenaar Bilgen, Quirijn A. J. Eijsbouts, Guido Mannaerts, Bart A. van Wagensveld
Publikováno v: The lancet. Gastroenterology & hepatology, 5(10), 900-907. HANLEY & BELFUS-ELSEVIER INC
LIR!C study group 2020, ' Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease : retrospective long-term follow-up of the LIR!C trial ', The Lancet Gastroenterology and Hepatology, vol. 5, no. 10, pp. 900-907 . https://doi.org/10.1016/S2468-1253(20)30117-5
The Lancet Gastroenterology and Hepatology, 5(10), 900-907. Elsevier Ltd
lancet. Gastroenterology & hepatology, 5(10), 900-907. Elsevier Limited
BACKGROUND: The LIR!C trial showed that laparoscopic ileocaecal resection is a cost-effective treatment that has similar quality-of-life outcomes to treatment with infliximab, an anti-tumour necrosis factor (TNF) drug. We aimed to compare long-term o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e5752a7757a14a7ceff01b5b9c7a95a
https://doi.org/10.1016/s2468-1253(20)30117-5
Zobrazit plný text záznamu
5
Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal cancer Screening
Autor: An K. Stroobants, Anneke J van Vuuren, Ernst J. Kuipers, Manon C.W. Spaander, Patrick M.M. Bossuyt, Evelien Dekker, Rosalie C. Mallant-Hent, Esmée J. Grobbee, Iris Lansdorp-Vogelaar, Manon van der Vlugt
Publikováno v: Clinical Gastroenterology and Hepatology, 18(3), 667-+. W.B. Saunders
Clinical gastroenterology and hepatology, 18(3), 667-675.e1. W.B. Saunders Ltd
Background & Aims: We compared the diagnostic yields of colonoscopy, flexible sigmoidoscopy, and fecal immunochemical tests (FITs) in colorectal cancer (CRC) screening. Methods: A total of 30,007 asymptomatic persons, 50–74 years old, were invited
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7fb9c4724e6fa35f32dd810efc10d54
https://pure.eur.nl/en/publications/bbb44261-4f3e-4ab7-a584-ee37ced37eb8
Zobrazit plný text záznamu
6
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial
Autor: Job H.C. Peters, Sijbrand Hofker, Marno C.M. Rijk, Theo J.M. van Ditzhuijsen, Donald L. van der Peet, Annekatrien Depla, John Maring, Hans Brouwer, Geert R. D'Haens, Anna A. W. van Geloven, Patrick M.M. Bossuyt, Huib A. Cense, Paul Kingma, Djuna Cahen, Meindert N. Sosef, Esther C. J. Consten, Arnold van de Laar, H. B. A. C. Stockmann, Emma J. Eshuis, Richard van Hillegersberg, Ernst Jan Spillenaar Bilgen, Karlien F. Bruin, Bregje Mol, Alexander P.J. Houdijk, Liekele Oostenbrug, Jeroen M. Jansen, Maarten J Boom, Robert E G J M Pierik, Gerard Dijkstra, Hubert A Prins, Rogier M P H Crolla, Rosalie C Mallant, Nanne K. H. de Boer, Jan van den Brande, Michael F. Gerhards, Ad A. van Bodegraven, Menno A. Brink, Bas Oldenburg, Pritesh Morar, Janneke van der Woude, Janindra Warusavitarne, Tjibbe J. Gardenbroek, E. Joline de Groof, Pieter C. F. Stokkers, Rob J. Lieverse, Eric J. Hazebroek, Marcel Spanier, Casper G. Noomen, Willem A. Bemelman, Cyriel Y. Ponsioen, Andreas Marinelli, Juda Vecht, Ailsa Hart, Nynke Talstra, Willem A. Marsman, Tessa Uiterwaal, Christianne J. Buskens, Nofel Mahmmod, Rachel L. West, A Jeroen de Groof, Sjoerd van der Werff, Clemens Bolwerk, Quirijn A. J. Eijsbouts, Edwin S. van der Zaag, Ruud Schouten, Bart A. van Wagensveld, Guido Mannaerts
Publikováno v: Ponsioen, C Y, de Groof, E J, Eshuis, E J, Gardenbroek, T J, Bossuyt, P M M, Hart, A, Warusavitarne, J, Buskens, C J, van Bodegraven, A A, Brink, M A, Consten, E C J, van Wagensveld, B A, Rijk, M C M, Crolla, R M P H, Noomen, C G, Houdijk, A P J, Mallant, R C, Boom, M, Marsman, W A, Stockmann, H B, Mol, B, de Groof, A J, Stokkers, P C, D'Haens, G R, Bemelman, W A, LIR!C study group & LIR!C study group 2017, ' Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease : a randomised controlled, open-label, multicentre trial ', The Lancet Gastroenterology and Hepatology, vol. 2, no. 11, pp. 785-792 . https://doi.org/10.1016/S2468-1253(17)30248-0
Lancet Gastroenterology & Hepatology, 2(11), 785-792. Elsevier Ltd.
The Lancet Gastroenterology and Hepatology, 2(11), 785-792. Elsevier Ltd
lancet. Gastroenterology & hepatology, 2(11), 785-792. Elsevier Limited
Background Treatment of patients with ileocaecal Crohn's disease who have not responded to conventional therapy is commonly scaled up to biological agents, but surgery can also offer excellent short-term and long-term results. We compared laparoscopi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb34b19ce17cea4fe23427f76644e5c7
https://doi.org/10.1016/s2468-1253(17)30248-0
Zobrazit plný text záznamu
7
The Amsterdam ReBus progressor cohort: identification of 165 Barrett's surveillance patients who progressed to early neoplasia and 723 nonprogressor patients
Autor: C A Seldenrijk, Bas L.A.M. Weusten, A. Bureo Gonzalez, EJ Schoon, Jacques J. Bergman, Sybren L. Meijer, David F. Boerwinkel, Roos E. Pouw, Lucas C. Duits, Esther Klaver, G J A Offerhaus, Rosalie C. Mallant-Hent, K. K. Krishnadath, Mike Visser, F. J. W. Ten Kate
Publikováno v: Diseases of the Esophagus, 32(9). Wiley-Blackwell
Duits, L C, Klaver, E, Bureo Gonzalez, A, Boerwinkel, D F, Ten Kate, F J W, Offerhaus, G J A, Meijer, S L, Visser, M, Seldenrijk, C A, Krishnadath, K K, Schoon, E J, Weusten, B L A M, Mallant-Hent, R C, Pouw, R E & Bergman, J J G H M 2019, ' The Amsterdam ReBus progressor cohort : identification of 165 Barrett's surveillance patients who progressed to early neoplasia and 723 nonprogressor patients ', Diseases of the Esophagus, vol. 32, no. 9 . https://doi.org/10.1093/dote/doy037
Diseases of the esophagus, 32(9). Wiley-Blackwell
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 32(9). Wiley-Blackwell
SUMMARYPatient selection is suboptimal in most studies focused on identifying biological markers for neoplastic progression in Barrett's esophagus (BE). This study aims to describe a stringently selected community-based case-control cohort of non-dys
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f5f2fdff1084fba3cc5e0038c261257
https://doi.org/10.1093/dote/doy037
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje